000 01260 a2200349 4500
005 20250516222607.0
264 0 _c20141215
008 201412s 0 0 eng d
022 _a1479-5876
024 7 _a10.1186/1479-5876-12-191
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYano, Hiroshi
245 0 0 _aIpilimumab augments antitumor activity of bispecific antibody-armed T cells.
_h[electronic resource]
260 _bJournal of translational medicine
_cJul 2014
300 _a191 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Bispecific
_ximmunology
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aCD3 Complex
_ximmunology
650 0 4 _aCTLA-4 Antigen
_ximmunology
650 0 4 _aCell Line, Tumor
650 0 4 _aHumans
650 0 4 _aIpilimumab
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aThakur, Archana
700 1 _aTomaszewski, Elyse N
700 1 _aChoi, Minsig
700 1 _aDeol, Abhinav
700 1 _aLum, Lawrence G
773 0 _tJournal of translational medicine
_gvol. 12
_gp. 191
856 4 0 _uhttps://doi.org/10.1186/1479-5876-12-191
_zAvailable from publisher's website
999 _c23993903
_d23993903